IXICO (LON:IXI – Get Free Report) issued its quarterly earnings results on Tuesday. The company reported GBX (1.21) earnings per share for the quarter, Digital Look Earnings reports. IXICO had a negative return on equity of 13.74% and a negative net margin of 25.27%.The business had revenue of GBX 395 million for the quarter.
IXICO Stock Performance
Shares of IXICO stock opened at GBX 8.30 on Thursday. The company has a current ratio of 3.03, a quick ratio of 4.90 and a debt-to-equity ratio of 1.53. The business has a 50-day moving average price of GBX 7.37 and a two-hundred day moving average price of GBX 9.44. IXICO has a 1-year low of GBX 6.26 and a 1-year high of GBX 15. The company has a market cap of £18.10 million, a P/E ratio of -4.49, a PEG ratio of -0.38 and a beta of 0.07.
About IXICO
By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.
Featured Stories
- Five stocks we like better than IXICO
- Freight Boom: The Hormuz Blockade Payday
- The Palantir Paradox—Record Numbers and a Stock That Won’t Cooperate
- TJX Companies Fires on All Cylinders With 9% Revenue Growth
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
Receive News & Ratings for IXICO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IXICO and related companies with MarketBeat.com's FREE daily email newsletter.
